… were at elevated risk of venous thromboembolism and were … mitigate the lethality of venous
thromboembolism) and those for … We focused our analyses on studies reporting statistically …

… preventing the development of thromboembolism could reduce COVID-… thromboembolism
risk among COVID-19 patients and to potentially reduce the mortality risk of thromboembolism. …

… patients with COVID‐19 are at increased risk of developing VTE as well. Because of the
unavailability of sufficient data within our meta‐analysis, we were unable to provide prevalence …

Objective JAK inhibitor therapies are effective treatment options for immune‐mediated
inflammatory diseases (IMIDs), but their use has been limited by venous thromboembolism (VTE) …

… -29.4) had been classified as high risk according to the Khorana score. In … risk of venous
thromboembolism for thromboprophylaxis; however, most events occur outside this high-risk …

… Current guidelines recommend extending anticoagulation treatment in patients with
unprovoked venous thromboembolism (VTE) who have a low or moderate bleeding risk. …

… resulting in high risk of venous thromboembolism events (… meta-analysis showed a
relatively high prevalence of DVT and PE in the range of about 30%. Previous relevant meta-analyses …

… thromboembolism (VTE) is divergent. We conducted a systematic review and meta-analysis …
evaluating the associations of physical activity with VTE risk. MEDLINE, Embase, Web of …

… illnesses,134 135 as well as the ATE risk of patients with community-acquired pneumonia,…
-19 in the present meta-analysis. In the context of the increased risk of bleeding138 and …

… We used random effects meta analyses to pool rates from each study cohort, with cohorts …
Given that we calculated rates of recurrent VTE in our analysis based on person time at risk …